A Clinical Study of 6MW3211 in Patients With Renal Cancer

Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer.

NCT00656734 ·Status: COMPLETED ·Phase: PHASE1

Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Progresses During or After Prior Systemic Anti-angiogenic Regimen

NCT03013335 ·Status: COMPLETED ·Phase: PHASE2

Study of CP-461 in Patients With Advanced Renal Cell Cancer

NCT00036036 ·Status: COMPLETED ·Phase: PHASE2

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

NCT07011719 ·Status: RECRUITING ·Phase: PHASE3

A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

NCT03141177 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Cediranib Maleate in Treating Patients With Recurrent or Metastatic Kidney Cancer That Cannot Be Removed By Surgery

NCT00227760 ·Status: COMPLETED ·Phase: PHASE2

A Study of AK112 Monotherapy in Advanced/Metastatic Renal Cell Carcinoma

NCT06472895 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread

NCT04810078 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Retrospective Study on the Safety of Nivolumab in Patients With mRCC and Renal Failure

NCT07117409 ·Status: TERMINATED

CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer

NCT06399419 ·Status: RECRUITING ·Phase: PHASE1

Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

NCT03055013 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Nivolumab in Treating Patients With High-Risk Kidney Cancer Before Surgery

NCT02595918 ·Status: TERMINATED ·Phase: PHASE1

Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer

NCT05239533 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

MLN0128 and MLN0128 + MLN1117 Compared With Everolimus in the Treatment of Adults With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma

NCT02724020 ·Status: COMPLETED ·Phase: PHASE2

6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer

NCT00003390 ·Status: COMPLETED ·Phase: PHASE2

A Study of Belzutifan (MK-6482) in Participants With Advanced Renal Cell Carcinoma (MK-6482-013)

NCT04489771 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

RAD001 for Non-clear Cell Renal Cell Carcinoma (RCC)

NCT00830895 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of rhuMAb VEGF to Treat Metastatic Renal Cell Carcinoma

NCT00061178 ·Status: WITHDRAWN ·Phase: PHASE3

Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

NCT05663710 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma

NCT06321250 ·Status: RECRUITING ·Phase: PHASE1

Pembrolizumab and Axitinib as Neoadjuvant Therapy for Locally Advanced Non-metastatic Clear Cell Renal Cell Carcinoma

NCT04995016 ·Status: UNKNOWN ·Phase: PHASE2

Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer

NCT00019539 ·Status: COMPLETED ·Phase: PHASE2

Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients

NCT06577961 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Phase III Study of Sorafenib in Patients With Renal Cell Carcinoma (RCC)

NCT00586105 ·Status: COMPLETED ·Phase: PHASE3

Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

NCT03937219 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3